New York Providers Prescribing Compounded Ketamine to Patients Should Be Aware of the October 10, 2023 FDA Alert

The only psychedelic substance which can be prescribed by New York providers at this time is ketamine (for off-label use) and Spravato (which only includes the esketamine molecule). While Spravato has been approved by the FDA for treatment of depression, ketamine is not currently FDA approved for such treatment. New York providers are prescribing compounded ketamine to Read More